NASDAQ:ARTV | Free Cash Flow | Artiva Biotherapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2023-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$20.95M$242,000.00-$21.19M
2025-12-31-$14.73M$421,000.00-$15.15M
2025-03-31-$19.84M$511,000.00-$20.35M
2024-12-31-$14.65M$64,000.00-$14.71M
2024-03-31-$15.09M$18,000.00-$15.1M
2023-12-31-$10.68M$636,000.00-$11.31M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$76.75M$2.59M-$79.34M
2024-12-31-$55.03M$642,000.00-$55.67M
2023-12-31-$47.43M$3.26M-$50.69M